Clearwater Capital Advisors, LLC Compugen LTD Transaction History

Clearwater Capital Advisors, LLC

  • $896 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023
SELL
$0.88 - $1.31 $942 - $1,403
-1,071 Reduced 8.25%
11,905 $11,000
Q4 2022

Jan 27, 2023
SELL
$0.58 - $1.2 $1,160 - $2,400
-2,000 Reduced 13.35%
12,976 $0
Q1 2022

May 03, 2022
BUY
$2.76 - $4.64 $3,311 - $5,568
1,200 Added 8.71%
14,976 $48,000
Q4 2021

Jan 26, 2022
BUY
$4.09 - $7.16 $56,343 - $98,636
13,776 New
13,776 $59,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.3M
Call Options Held
191K
Put Options Held
135K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Clearwater Capital Advisors, LLC Portfolio

Follow Clearwater Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email